Breast cancer is the most common cancer worldwide. Mammography screening and biopsy procedures for abnormal mammograms are the gold standard detection method, however, it is invasive, time-consuming, and labor-intensive. RNA biomarkers in circulating blood may be an alternative to the gold standard. We have adopted a multi-modal approach using Fourier transform infrared (FTIR) spectroscopy and Raman spectroscopy that provides a complete characterization of RNA biomarker fingerprints in the full spectrum. We have measured 99 patients’ serum samples and achieved a higher accuracy, specificity, and sensitivity using the multi-modal approach combined with machine learning analysis than using the individual techniques alone.
|